Cite
APA Citation
Bongiovanni, A. R., Zhao, P., Inan, S., Wiah, S., Shekarabi, A., Farkas, D. J., Watson, M. N., Wimmer, M. E., Ruff, M. R., & Rawls, S. M. (2022). multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats. Drug and alcohol dependence, 238, . http://access.bl.uk/ark:/81055/vdc_100163063073.0x00002c